Atlas Trials

Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer

Clinical trial NCT03964337 · TERMINATED

Trial details

NCT number
NCT03964337
Sponsor
Duke University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerProstate Cancer AdenocarcinomaNon-Metastatic
Start date
2020-03-17
Primary completion
2021-06-04
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.